CellMax Life Earns FDA Breakthrough Device Designation for Colon Cancer & Pre-Cancerous Adenomas Screening Blood Test
August 25, 2021 06:00 ET
|
CellMax Life
SUNNYVALE, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- CellMax Life, a molecular diagnostics company, announced today that its FirstSight™ pre-cancer and cancer detection blood test has received...
LERMA Creates Campaign to Raise Awareness During Colorectal Cancer Awareness Month
March 05, 2020 09:10 ET
|
Colon Cancer Coalition
Dallas & Minneapolis, March 05, 2020 (GLOBE NEWSWIRE) -- In recognition of Colorectal Cancer Awareness Month this March, LERMA, a Dallas-based next-generation communications agency dedicated to...
Todos Medical Announces Legacy Convertible Note Extension, Lock-Up Agreements, and New Debt Financing
February 25, 2020 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Receives Notice of Allowance from European Patent Office Covering Diagnosis of Solid Tumors Using AI to Analyze Blood
February 19, 2020 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Signs Binding Term Sheet with HWH World for Network Marketing of Blood Tests for the Early Detection of Breast Cancer
September 13, 2019 07:30 ET
|
Todos Medical Ltd.
REHOVOT, Israel and SINGAPORE, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the...
Todos Medical Enters into MOU to Expand Existing Early Detection Breast Cancer Blood Test Distribution Partnership with Orot+ into Japan
September 03, 2019 13:29 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Announces Positive Clinical Trial Data for Breast Cancer Blood Test TM-B1 in Dense Breasts
June 03, 2019 08:00 ET
|
Todos Medical Ltd.
TM-B1 demonstrates 80% accuracy vs. 50% accuracy for current gold standardTodos Medical to attend 2019 ASCO Annual Meeting in Chicago, IL REHOVOT, Israel, June 03, 2019 (GLOBE NEWSWIRE) -- Todos...
Todos Medical Announces Voting Results from 2019 Annual Shareholder Meeting
May 03, 2019 08:52 ET
|
Todos Medical Ltd.
REHOVOT, Israel and NEW YORK, May 03, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the...
Todos Medical Appoints Dr. Colin Bier to Its Board of Directors
March 27, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, March 27, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture Agreement with Amarantus Bioscience
February 28, 2019 09:30 ET
|
Todos Medical Ltd.; Amarantus Bioscience Holdings, Inc.
JV to focus on the development of Alzheimer’s blood diagnostic LymPro Test 2.0 REHOVOT, Israel and NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage...